If small caps are your thing, check out these two…
The post 2 buy-rated small cap ASX shares appeared first on The Motley Fool Australia. –
At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future.
Two that investors might want to get better acquainted with are listed below. Here’s what you need to know about them:
Hipages Group Holdings Ltd (ASX: HPG)
The first small cap to look at is Hipages. It is a leading Australian-based online platform and software as a service (SaaS) provider.
The company’s platform connects tradies with residential and commercial consumers, providing job leads from homeowners and organisations looking for qualified professionals. It also offers tradies a solution to run their business from, cutting down on general administration duties.
Goldman Sachs is a big fan of the company and believes it is well-placed for growth over the next decade. The broker notes that Hipages is building a compelling marketplace, with a healthy balance between consumers and tradies. It has also been pleased with recent app download data, website visits, and job ad growth.
It expects more of the same in the future and sees scope for Hipages to grow its share of industry advertising spend from 5% to upwards of 60% eventually.
Goldman currently has a buy rating and $3.40 price target on its shares.
SILK Laser Australia Limited (ASX: SLA)
Another small cap ASX share to watch is SILK Laser. It is a laser, skin care, and cosmetic injections company.
Thanks to increasing demand and store network expansion, SILK has been growing at a strong rate in FY 2021. For example, during the first half, SILK reported a 62% increase in network sales to $44.9 million and a 305% increase in net profit to $4.7 million.
At that point, management advised that it intended to grow its network by 6 to 10 new clinics per annum from 60 up to a target of approximately 150 clinics. However, it has just accelerated its network growth by signing an agreement to acquire Australian Skin Clinics in Australia and The Cosmetic Clinic in New Zealand for $47 million. This adds a total of 56 more clinics to its network, taking its total to 117.
Management notes that it also solidifies its number two market position and opens the company up to new markets.
Analysts at Ord Minnett are positive on the company and currently have a buy rating and $10.69 price target on its shares.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of May 24th 2021
SILK Laser (ASX: SLA) share price climbs on equity raise update
2 growing ASX tech shares this broker rates very highly
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Hipages Group Holdings Ltd. The Motley Fool Australia has recommended SILK Laser Australia Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.